{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T06:27:16Z","timestamp":1769063236614,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"China Medical University Hospital (CMUH), Taichung, Taiwan","award":["DMR-113-049"],"award-info":[{"award-number":["DMR-113-049"]}]},{"name":"National Science and Technology Council, Taiwan","award":["NSTC 113-2221-E-039-018"],"award-info":[{"award-number":["NSTC 113-2221-E-039-018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-32481-1","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T17:18:10Z","timestamp":1765991890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Personalized intensity modulation radiation therapy auto-planning for esophageal cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Chih-Yuan","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Cheng","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Ching","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Cheng","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ti-Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Ming","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"32481_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13019-020-01202-2","volume":"15","author":"QL Xu","year":"2020","unstructured":"Xu, Q. L., Li, H., Zhu, Y. J. & Xu, G. The treatments and postoperative complications of esophageal cancer: a review. J. Cardiothorac. Surg. 15, 163. https:\/\/doi.org\/10.1186\/s13019-020-01202-2 (2020).","journal-title":"J. Cardiothorac. Surg."},{"key":"32481_CR2","unstructured":"Network, N. C. C. Esophageal and Esophagogastric Junction Cancers Version 4.2024, https:\/\/www.nccn.org\/login?ReturnURL=https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/esophageal.pdf (."},{"key":"32481_CR3","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s13014-019-1443-5","volume":"14","author":"C Ling","year":"2019","unstructured":"Ling, C. et al. A hybrid automated treatment planning solution for esophageal cancer. Radiat. Oncol. 14, 232. https:\/\/doi.org\/10.1186\/s13014-019-1443-5 (2019).","journal-title":"Radiat. Oncol."},{"key":"32481_CR4","doi-asserted-by":"publisher","first-page":"735062","DOI":"10.3389\/fonc.2021.735062","volume":"11","author":"Y Shao","year":"2021","unstructured":"Shao, Y. et al. Investigation of predictors to achieve acceptable lung dose in T-Shaped upper and middle esophageal cancer with IMRT and VMAT. Front. Oncol. 11, 735062. https:\/\/doi.org\/10.3389\/fonc.2021.735062 (2021).","journal-title":"Front. Oncol."},{"key":"32481_CR5","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1080\/0284186X.2017.1349928","volume":"56","author":"CR Hansen","year":"2017","unstructured":"Hansen, C. R. et al. Automatic treatment planning facilitates fast generation of high-quality treatment plans for esophageal cancer. Acta Oncol. 56, 1495\u20131500. https:\/\/doi.org\/10.1080\/0284186X.2017.1349928 (2017).","journal-title":"Acta Oncol."},{"key":"32481_CR6","doi-asserted-by":"publisher","first-page":"20180270","DOI":"10.1259\/bjr.20180270","volume":"91","author":"M Hussein","year":"2018","unstructured":"Hussein, M., Heijmen, B. J. M., Verellen, D. & Nisbet, A. Automation in intensity modulated radiotherapy treatment planning-a review of recent innovations. Br. J. Radiol. 91, 20180270. https:\/\/doi.org\/10.1259\/bjr.20180270 (2018).","journal-title":"Br. J. Radiol."},{"key":"32481_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.semradonc.2019.02.003","volume":"29","author":"KL Moore","year":"2019","unstructured":"Moore, K. L. Automated radiotherapy treatment planning. Semin Radiat. Oncol. 29, 209\u2013218. https:\/\/doi.org\/10.1016\/j.semradonc.2019.02.003 (2019).","journal-title":"Semin Radiat. Oncol."},{"key":"32481_CR8","doi-asserted-by":"publisher","first-page":"153303381987392","DOI":"10.1177\/1533033819873922","volume":"18","author":"C Wang","year":"2019","unstructured":"Wang, C., Zhu, X., Hong, J. C. & Zheng, D. Artificial intelligence in radiotherapy treatment planning: present and future. Technol. Cancer Res. Treat. 18, 1533033819873922. https:\/\/doi.org\/10.1177\/1533033819873922 (2019).","journal-title":"Technol. Cancer Res. Treat."},{"key":"32481_CR9","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13014-023-02334-0","volume":"18","author":"K Hirotaki","year":"2023","unstructured":"Hirotaki, K. et al. Fully automated volumetric modulated Arc therapy planning for locally advanced rectal cancer: feasibility and efficiency. Radiat. Oncol. 18, 147. https:\/\/doi.org\/10.1186\/s13014-023-02334-0 (2023).","journal-title":"Radiat. Oncol."},{"key":"32481_CR10","unstructured":"EVIQ. Cancer Treatments Online: Cancer Institute NSW. Available from: (2019). https:\/\/www.eviq.org.au\/radiation-oncology. Accessed September 25,."},{"key":"32481_CR11","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00066-020-01581-4","volume":"196","author":"M Kirli Bolukbas","year":"2020","unstructured":"Kirli Bolukbas, M. & Karaca, S. Effect of lung volume on helical radiotherapy in esophageal cancer: are there predictive factors to achieve acceptable lung doses? Strahlenther Onkol. 196, 805\u2013812. https:\/\/doi.org\/10.1007\/s00066-020-01581-4 (2020).","journal-title":"Strahlenther Onkol"},{"key":"32481_CR12","doi-asserted-by":"publisher","first-page":"9913","DOI":"10.2147\/IJGM.S336269","volume":"14","author":"J Hong","year":"2021","unstructured":"Hong, J., Han, J. H., Luo, H. L. & Song, Y. Q. Optimization of minimum segment width parameter in the Intensity-Modulated radiotherapy plan for esophageal cancer. Int. J. Gen. Med. 14, 9913\u20139921. https:\/\/doi.org\/10.2147\/IJGM.S336269 (2021).","journal-title":"Int. J. Gen. Med."},{"key":"32481_CR13","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.1120\/jacmp.v15i3.4732","volume":"15","author":"P Ma","year":"2014","unstructured":"Ma, P., Wang, X., Xu, Y., Dai, J. & Wang, L. Applying the technique of volume-modulated Arc radiotherapy to upper esophageal carcinoma. J. Appl. Clin. Med. Phys. 15, 4732. https:\/\/doi.org\/10.1120\/jacmp.v15i3.4732 (2014).","journal-title":"J. Appl. Clin. Med. Phys."},{"key":"32481_CR14","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.ijrobp.2005.08.002","volume":"64","author":"SL Wang","year":"2006","unstructured":"Wang, S. L. et al. Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery. Int. J. Radiat. Oncol. Biol. Phys. 64, 692\u2013699. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.08.002 (2006).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"32481_CR15","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1111\/1759-7714.14661","volume":"13","author":"C X Hsu","year":"2022","unstructured":"X. Hsu, C. et al. Integrating (18) F-FDG PET\/CT with lung dose-volume for assessing lung inflammatory changes after arc-based radiotherapy for esophageal cancer: A pilot study. Thorac. Cancer. 13, 3114\u20133123. https:\/\/doi.org\/10.1111\/1759-7714.14661 (2022).","journal-title":"Thorac. Cancer"},{"key":"32481_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s13014-018-1069-z","volume":"13","author":"LC Mendez","year":"2018","unstructured":"Mendez, L. C. et al. Evaluation of a new predictor of heart and left anterior descending artery dose in patients treated with adjuvant radiotherapy to the left breast. Radiat. Oncol. 13, 124. https:\/\/doi.org\/10.1186\/s13014-018-1069-z (2018).","journal-title":"Radiat. Oncol."},{"key":"32481_CR17","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fonc.2020.00153","volume":"10","author":"G Cai","year":"2020","unstructured":"Cai, G., Li, C., Yu, J. & Meng, X. Heart dosimetric parameters were associated with cardiac events and overall survival for patients with locally advanced esophageal cancer receiving definitive radiotherapy. Front. Oncol. 10, 153. https:\/\/doi.org\/10.3389\/fonc.2020.00153 (2020).","journal-title":"Front. Oncol."},{"key":"32481_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ctro.2019.04.016","volume":"17","author":"C Xu","year":"2019","unstructured":"Xu, C. et al. Heart and lung doses are independent predictors of overall survival in esophageal cancer after chemoradiotherapy. Clin. Transl Radiat. Oncol. 17, 17\u201323. https:\/\/doi.org\/10.1016\/j.ctro.2019.04.016 (2019).","journal-title":"Clin. Transl Radiat. Oncol."},{"key":"32481_CR19","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.rpor.2020.02.005","volume":"25","author":"M Vosmik","year":"2020","unstructured":"Vosmik, M. et al. Cardiotoxicity of radiation therapy in esophageal cancer. Rep. Pract. Oncol. Radiother. 25, 318\u2013322. https:\/\/doi.org\/10.1016\/j.rpor.2020.02.005 (2020).","journal-title":"Rep. Pract. Oncol. Radiother"},{"key":"32481_CR20","doi-asserted-by":"publisher","first-page":"e0252552","DOI":"10.1371\/journal.pone.0252552","volume":"16","author":"Z Kang","year":"2021","unstructured":"Kang, Z., Chen, S., Shi, L., He, Y. & Gao, X. Predictors of heart and lung dose in left-sided breast cancer treated with VMAT relative to 3D-CRT: A retrospective study. PLoS One. 16, e0252552. https:\/\/doi.org\/10.1371\/journal.pone.0252552 (2021).","journal-title":"PLoS One"},{"key":"32481_CR21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.adro.2017.03.006","volume":"2","author":"C Xu","year":"2017","unstructured":"Xu, C. et al. Dosimetric and clinical outcomes after volumetric modulated Arc therapy for carcinoma of the thoracic esophagus. Adv. Radiat. Oncol. 2, 325\u2013332. https:\/\/doi.org\/10.1016\/j.adro.2017.03.006 (2017).","journal-title":"Adv. Radiat. Oncol."},{"key":"32481_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3857\/roj.2017.00241","volume":"36","author":"KH Choi","year":"2018","unstructured":"Choi, K. H., Kim, J., Lee, S. W., Kang, Y. N. & Jang, H. Dosimetric comparison between modulated Arc therapy and static intensity modulated radiotherapy in thoracic esophageal cancer: a single institutional experience. Radiat. Oncol. J. 36, 63\u201370. https:\/\/doi.org\/10.3857\/roj.2017.00241 (2018).","journal-title":"Radiat. Oncol. J."},{"key":"32481_CR23","doi-asserted-by":"publisher","first-page":"5266","DOI":"10.3748\/wjg.v18.i37.5266","volume":"18","author":"L Yin","year":"2012","unstructured":"Yin, L. et al. Volumetric-modulated Arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison. World J. Gastroenterol. 18, 5266\u20135275. https:\/\/doi.org\/10.3748\/wjg.v18.i37.5266 (2012).","journal-title":"World J. Gastroenterol."},{"key":"32481_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/pro6.1108","volume":"5","author":"H Su","year":"2021","unstructured":"Su, H. et al. Dosimetric effects related to collimator angle optimization in intensity-modulated radiotherapy planning for gastric cancer. Precision Radiation Oncol. 5, 25\u201333. https:\/\/doi.org\/10.1002\/pro6.1108 (2021).","journal-title":"Precision Radiation Oncol."},{"key":"32481_CR25","doi-asserted-by":"publisher","first-page":"e0202628","DOI":"10.1371\/journal.pone.0202628","volume":"13","author":"L Shi","year":"2018","unstructured":"Shi, L., Lai, Y., Chen, S., Fu, L. & Lin, Q. Dosimetric superiority of IMRT with jaw tracking technique for whole esophagus and T-shaped field radiotherapy in advanced esophageal cancer. PLoS One. 13, e0202628. https:\/\/doi.org\/10.1371\/journal.pone.0202628 (2018).","journal-title":"PLoS One"},{"key":"32481_CR26","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/dote.12144","volume":"27","author":"CY Lin","year":"2014","unstructured":"Lin, C. Y. et al. Dosimetric and efficiency comparison of high-dose radiotherapy for esophageal cancer: volumetric modulated Arc therapy versus fixed-field intensity-modulated radiotherapy. Dis. Esophagus. 27, 585\u2013590. https:\/\/doi.org\/10.1111\/dote.12144 (2014).","journal-title":"Dis. Esophagus"},{"key":"32481_CR27","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/j.prro.2012.06.009","volume":"3","author":"V Batumalai","year":"2013","unstructured":"Batumalai, V., Jameson, M. G., Forstner, D. F., Vial, P. & Holloway, L. C. How important is dosimetrist experience for intensity modulated radiation therapy? A comparative analysis of a head and neck case. Pract. Radiat. Oncol. 3, e99\u2013e106. https:\/\/doi.org\/10.1016\/j.prro.2012.06.009 (2013).","journal-title":"Pract. Radiat. Oncol."},{"key":"32481_CR28","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/1471-2407-11-466","volume":"11","author":"CN Hurt","year":"2011","unstructured":"Hurt, C. N. et al. SCOPE1: a randomised phase II\/III multicentre clinical trial of definitive chemoradiation, with or without cetuximab, in carcinoma of the oesophagus. BMC Cancer. 11, 466. https:\/\/doi.org\/10.1186\/1471-2407-11-466 (2011).","journal-title":"BMC Cancer"},{"key":"32481_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.jtho.2016.10.002","volume":"12","author":"SG Swisher","year":"2017","unstructured":"Swisher, S. G. et al. Final results of NRG oncology RTOG 0246: an Organ-Preserving selective resection strategy in esophageal cancer patients treated with definitive chemoradiation. J. Thorac. Oncol. 12, 368\u2013374. https:\/\/doi.org\/10.1016\/j.jtho.2016.10.002 (2017).","journal-title":"J. Thorac. Oncol."},{"key":"32481_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.rpor.2014.12.006","volume":"20","author":"L Vieillevigne","year":"2015","unstructured":"Vieillevigne, L., Vidal, M., Izar, F. & Rives, M. Is dose escalation achievable for esophageal carcinoma? Rep. Pract. Oncol. Radiother. 20, 135\u2013140. https:\/\/doi.org\/10.1016\/j.rpor.2014.12.006 (2015).","journal-title":"Rep. Pract. Oncol. Radiother"},{"key":"32481_CR31","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.ijrobp.2022.11.006","volume":"115","author":"J You","year":"2023","unstructured":"You, J. et al. High-Dose versus Standard-Dose Intensity-Modulated radiotherapy with concurrent Paclitaxel plus carboplatin for patients with thoracic esophageal squamous cell carcinoma: A Randomized, Multicenter, Open-Label, phase 3 superiority trial. Int. J. Radiat. Oncol. Biol. Phys. 115, 1129\u20131137. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.11.006 (2023).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"32481_CR32","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ijrobp.2007.10.056","volume":"70","author":"X Wei","year":"2008","unstructured":"Wei, X. et al. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int. J. Radiat. Oncol. Biol. Phys. 70, 707\u2013714. https:\/\/doi.org\/10.1016\/j.ijrobp.2007.10.056 (2008).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"32481_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.ijrobp.2013.07.008","volume":"87","author":"J Fukada","year":"2013","unstructured":"Fukada, J. et al. Symptomatic pericardial effusion after chemoradiation therapy in esophageal cancer patients. Int. J. Radiat. Oncol. Biol. Phys. 87, 487\u2013493. https:\/\/doi.org\/10.1016\/j.ijrobp.2013.07.008 (2013).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"32481_CR34","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1038\/s41598-018-38414-5","volume":"9","author":"JJ Tonison","year":"2019","unstructured":"Tonison, J. J. et al. Radiation pneumonitis after Intensity-Modulated radiotherapy for esophageal cancer: institutional data and a systematic review. Sci. Rep. 9, 2255. https:\/\/doi.org\/10.1038\/s41598-018-38414-5 (2019).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32481-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32481-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32481-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T14:39:47Z","timestamp":1769006387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-32481-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["32481"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-32481-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2749"}}